Trichinella spiralis infection-induced ursodeoxycholic acid ameliorates colitis by regulating dendritic cells and macrophages via NLRP3 inflammasome signaling pathway
This study demonstrates that *Trichinella spiralis* infection ameliorates colitis by reshaping the gut microbiota to enrich *Bacteroides acidifaciens*, which produces ursodeoxycholic acid (UDCA) that binds to TGR5 receptors on dendritic cells and macrophages to inhibit NLRP3 inflammasome activation, reduce inflammatory cytokines, and restore intestinal barrier integrity.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human gut is home to a vast, invisible ecosystem of bacteria, fungi, and viruses that work alongside our immune system to keep us healthy. When this community falls out of balance, a condition known as dysbiosis, it can trigger chronic inflammation in the intestines, leading to diseases like inflammatory bowel disease. For decades, scientists have noticed a curious pattern: regions where people are frequently infected by parasitic worms tend to have lower rates of these autoimmune conditions. This observation sparked the "hygiene hypothesis," suggesting that the absence of these ancient parasites might be leaving our immune systems without the necessary training to regulate themselves properly. While some researchers have experimented with intentionally infecting patients with worms to treat their diseases, this approach carries significant risks, as the parasites themselves can cause illness. The challenge has been to understand exactly how these worms calm the immune system without actually making the patient sick, hoping to find a safe, natural component of the interaction that could be used as a medicine.
A team of researchers at Jilin Agricultural University in China has taken a significant step toward solving this puzzle by tracing the path from a specific parasite to a specific chemical that soothes the gut. They focused on Trichinella spiralis, a parasitic worm that infects pigs and humans, often through undercooked meat. In their study, they first confirmed that mice infected with this worm were protected from developing severe intestinal inflammation caused by a chemical irritant. However, they suspected the worm itself was not the direct healer. To test this, they treated mice with strong antibiotics to wipe out their natural gut bacteria before infecting them with the worm. These mice, lacking their microbial community, suffered much worse from the infection and did not receive the same protective benefits against inflammation. This result pointed to a crucial conclusion: the worm was not acting alone; it was reshaping the gut's bacterial landscape, and those new bacteria were the ones doing the actual work of calming the immune system.
To find out which bacteria were responsible, the researchers took fecal samples from the protected, worm-infected mice and transplanted them into mice that had active intestinal inflammation but no worms. The recipients of this transplant recovered, showing that the specific mix of bacteria induced by the worm was sufficient to cure the disease. By analyzing the DNA of these bacteria and the chemical compounds they produced, the team identified a specific species, Bacteroides acidifaciens, as a key player. This bacterium was far more abundant in the protected mice. The researchers then discovered what this bacterium was doing: it was acting as a chemical factory, converting a common bile acid produced by the liver into a different, more potent form called ursodeoxycholic acid, or UDCA. Bile acids are substances the body uses to digest fats, but they also act as signaling molecules that talk to the immune system.
The study went further to prove that this specific chemical, UDCA, was the true agent of healing. When the researchers gave UDCA directly to mice with inflamed guts, it reduced their symptoms just as effectively as the bacterial transplant. They then looked at how this chemical worked on a cellular level. They found that UDCA binds to a specific receptor on the surface of immune cells called dendritic cells and macrophages. These cells are like the sentinels of the immune system, constantly scanning for threats. In inflamed guts, these sentinels often overreact, triggering a violent inflammatory response. UDCA acts as a brake, binding to the receptor and stopping the cells from activating a dangerous internal alarm system known as the NLRP3 inflammasome. When this alarm is silenced, the cells stop releasing the toxic chemicals that damage the intestinal lining, allowing the tissue to heal.
The researchers also demonstrated that this process relies on a specific enzyme produced by the Bacteroides acidifaciens bacteria, which acts like a pair of molecular scissors to cut the original bile acid into the healing form. When they engineered a harmless bacterium to produce this same enzyme, it successfully increased levels of the healing chemical in the gut and reduced inflammation. This chain of events—parasite changes bacteria, bacteria make a specific enzyme, enzyme creates a healing chemical, chemical calms immune cells—provides a clear map of how a parasitic infection can lead to a cure. The findings suggest that instead of infecting patients with dangerous worms, doctors might one day be able to treat inflammatory bowel disease by boosting the levels of this specific beneficial bacterium or by administering the healing chemical directly. This approach offers a way to harness the immune-regulating power of the parasite's influence without the risks of the infection itself, turning a potential threat into a precise, safe therapeutic strategy.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.